文献速递骨肌技术与安全MRPETCT

脊柱骨转移瘤与良性红骨髓沉积的鉴别:脂肪抑制T2加权成像与脂肪分数图的价值比较

Differentiation of bone metastases from benign red marrow depositions of the spine: the role of fat-suppressed T2-weighted imaging compared to fat fraction map.
PubMed 文献 · Eur Radiol · 2022-07-07

研究纳入111个脊柱病灶(62个骨转移瘤、49个良性红骨髓沉积),由两名放射科医师独立测量脂肪抑制T2比值、脂肪分数及脂肪分数比值,比较两组参数并行ROC分析。骨转移瘤的脂肪抑制T2比值显著高于良性红骨髓沉积,脂肪分数及脂肪分数比值显著低于良性红骨髓沉积。各单项参数及其组合的AUC为0.941至0.980,各单项参数与组合之间AUC差异无统计学意义。

要点

  • 骨转移瘤脂肪抑制T2比值显著高于良性红骨髓沉积(2.638 vs. 1.155,p<0.001)。
  • 骨转移瘤脂肪分数及脂肪分数比值显著低于良性红骨髓沉积。
  • 脂肪抑制T2比值与脂肪分数图诊断效能相似,各单项及组合AUC为0.941至0.980且差异无统计学意义。

核心结论

  • 脂肪抑制T2比值、脂肪分数及脂肪分数比值无论是否组合,均可用于鉴别脊柱骨转移瘤与良性红骨髓沉积。

研究设计与样本

  • 共111个病灶,依据MR图像及骨扫描或PET-CT分为62个骨转移瘤和49个良性红骨髓沉积,采用脂肪抑制T2加权成像和脂肪分数图评估。

关键影像表现/征象

  • 骨转移瘤的脂肪抑制T2比值显著高于良性红骨髓沉积(2.638 vs. 1.155,p<0.001)。
  • 骨转移瘤的脂肪分数显著低于良性红骨髓沉积(3.554% vs. 20.038%,p<0.001)。
  • 骨转移瘤的脂肪分数比值显著低于良性红骨髓沉积(0.072 vs. 0.364,p<0.001)。

诊断标准与关键数值

  • 脂肪抑制T2比值定义为病灶脂肪抑制T2信号强度与正常骨髓脂肪抑制T2信号强度的比值。
  • 脂肪分数比值定义为病灶脂肪分数与正常骨髓脂肪分数的比值。
  • 各单项参数及其组合的ROC曲线AUC范围为0.941至0.980,各单项参数与组合之间AUC差异无统计学意义。

临床应用与阅片要点

  • 两名放射科医师独立在病灶ROI内测量脂肪抑制T2比值、脂肪分数及脂肪分数比值,取均值用于两组比较。
  • 脂肪抑制T2加权成像提供的诊断效能与脂肪分数图相似,可用于鉴别骨转移瘤与良性红骨髓沉积。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To differentiate bone metastases (BMs) from benign red marrow depositions (BRMs) of the spine using quantitative parameters derived from fat-suppressed T2-weighted imaging (T2 FS) and fat fraction (FF) map METHODS: One hundred eleven lesions, divided into 62 BMs and 49 BRMs according to MR images and either bone scan or PET-CT, were assessed with T2 FS and FF map. Two radiologists independently measured quantitative parameters from the ROIs in the lesions, including fat-suppressed (FS) T2 ratio (ratio of lesion FS T2 signal intensity [SI] to normal marrow FS T2 SI), FF, and FF ratio (ratio of lesion FF to normal marrow FF). The mean values of these parameters were compared between the two groups. To evaluate the diagnostic utilities of individual (FS T2 ratio, FF, and FF ratio) and combined parameters, ROC curves were analyzed. For the ROC curves among the individual parameters and their combinations, AUCs were compared.

RESULTS: The FS T2 ratio of BMs was significantly higher than that of BRMs (2.638 vs. 1.155 [p < 0.001]). The FF and FF ratio of BMs were significantly lower than those of BRMs (FF, 3.554% vs. 20.038% [p < 0.001]; FF ratio, 0.072 vs. 0.364 [p < 0.001]). The ROC AUCs of individual and combined parameters ranged from 0.941 to 0.980. The AUCs of all individual parameters and their combinations did not demonstrate statistically significant differences.

CONCLUSION: The FS T2 ratio, FF, and FF ratio can be useful in differentiating BMs from BRMs with or without any combination of the parameters.

KEY POINTS: • Quantitative parameters derived from fat-suppressed T2-weighted imaging and fat fraction map could be used to differentiate bone metastases from benign red marrow depositions with or without any combination of the parameters. • Quantitative parameters of fat-suppressed T2-weighted imaging provide diagnostic performance similar to those of fat fraction map in differentiating bone metastases from benign red marrow depositions.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Park, Do Huh. Differentiation of bone metastases from benign red marrow depositions of the spine: the role of fat-suppressed T2-weighted imaging compared to fat fraction map. Eur Radiol. 2022. PMID: 35798881. doi:10.1007/s00330-022-08965-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。